raremaprare-disease reference indexOrphadata 2026-06-23 · HPO 2026-09-01
ORPHA:466

Fatal familial insomnia

Synonyms: FFI

Type
Disease
Group
Disorder
Inheritance
Autosomal dominant
Age of onset
Adult
Status
active

A rare inherited human prion disease characterized by adult onset of progressive disturbance and loss of circadian rhythms, dysautonomia with increased sympathetic activity, and cognitive impairment with fluctuating vigilance, impaired long-term memory, disorientation, and oneiric states. Motor disturbances include myoclonus, cerebellar ataxia, and pyramidal signs. The disease rapidly leads to a somnolent or comatose state and is typically fatal after 9 or 30 months on average (bimodal course). Neuropathologic examination shows marked neuronal loss and gliosis predominantly in thalamic nuclei and inferior olives, while deposition of abnormal prion protein may be relatively sparse.

1

Names in Orphadata languages

12 of 12 languages
LangNameSynonyms
enFatal familial insomniaFFI
frInsomnie fatale familialeIFF
deInsomnie, familiäre fatale= en
esInsomnio familiar fatalIFF
itInsonnia familiare fatale= en
nlFatale familiale insomnie= en
ptInsónia familiar fatal
plŚmiertelna bezsenność rodzinnaŚmiertlena bezsenność rodzinna
csFatální familiární insomnie= en
ukФатальне сімейне безсоння
zh致死性家族性失眠症
trLetal ailesel insomnia

Definition in:

2

Cross-references

qualifier = Orphanet mapping relation
SourceCodeQualifierICD relationValidation
OMIM600072Evalidated
ICD-10A81.8NTBTattributedvalidated
ICD-118E02.2Especificvalidated
MONDO0010808Evalidated
MeSHD034062Evalidated
UMLSC0206042Evalidated
GARD6429Evalidated
MedDRA10072077Evalidated

E exact · NTBT this ORPHAcode is narrower than the target · BTNT broader than the target · ND not decided.

3

Classification

Preferential parent (Orphanet linearisation):

Parents in the classifications (1):

No children.

4

Genes

1 direct
GeneAssociationStatusHGNCEnsemblOMIMLocusNameSource of validation
PRNPDisease-causing germline mutation(s) inAssessedHGNC:9449ENSG0000017186717664020p13prion protein (Kanno blood group)20301407[PMID]
5

Prevalence and incidence

2 records
TypeClassValueAreaQualificationValidationSource
Cases/families27 casesWorldwideCase(s)ValidatedORPHANET
Point prevalence<1 / 1 000 000—WorldwideClass onlyValidatedORPHANET

Value is Orphadata's ValMoy: the mean estimate per 100 000 for prevalence and incidence, the number of cases or families for case reports.

6

HPO phenotypes

34 annotations · validated 2024-11-27
HPOTerm (as annotated by Orphanet)Diagnostic
Very frequent (99-80%)
HP:0012332Abnormal autonomic nervous system physiology
HP:0000726Dementia
HP:0100785InsomniaDiagnostic criterion
HP:0001336Myoclonus
Frequent (79-30%)
HP:0002071Abnormality of extrapyramidal motor functionDiagnostic criterion
HP:0000739Anxiety
HP:0001251Ataxia
HP:0031843Bradyphrenia
HP:0100543Cognitive impairment
HP:0000716Depression
HP:0001260Dysarthria
HP:0002015Dysphagia
HP:0000712Emotional labilityDiagnostic criterion
HP:0009926Epiphora
HP:0000738HallucinationsDiagnostic criterion
HP:0000975HyperhidrosisDiagnostic criterion
HP:0000822HypertensionDiagnostic criterion
HP:0006511Laryngeal stridorDiagnostic criterion
HP:5200044Reduced attention regulation
HP:5200360Short rem sleepDiagnostic criterion
HP:0033687Short term memory impairment
HP:0010535Sleep apneaDiagnostic criterion
HP:0006979Sleep-wake cycle disturbance
HP:0001649TachycardiaDiagnostic criterion
HP:0012660Thalamic hypometabolism in FDG PETDiagnostic criterion
Occasional (29-5%)
HP:0012689Abnormal pineal melatonin secretion
HP:0007256Abnormal pyramidal signDiagnostic criterion
HP:0002019Constipation
HP:0000651Diplopia
HP:0001945Fever
HP:0003118Increased circulating cortisol level
HP:0002371Loss of speech
HP:0001824Weight loss
Excluded (0%)
HP:0010850EEG with spike-wave complexes

Run the differential on the 4 obligate / very frequent terms

Annotation source: 29489284[PMID]_28324299[PMID]_30890351[PMID]_35501502[PMID]

7

Sources for this card